Literature DB >> 26498876

Photodynamic inactivation of Candida albicans by a tetracationic tentacle porphyrin and its analogue without intrinsic charges in presence of fluconazole.

Ezequiel D Quiroga1, S Jimena Mora1, M Gabriela Alvarez1, Edgardo N Durantini2.   

Abstract

The photodynamic inactivation mediated by 5,10,15,20-tetrakis[4-(3-N,N-dimethylaminopropoxy)phenyl]porphyrin (TAPP) and 5,10,15,20-tetrakis[4-(3-N,N,N-trimethylaminepropoxy)phenyl]porphyrin (TAPP(4+)) were compared in Candida albicans cells. A strong binding affinity was found between these porphyrins and the yeast cells. Photosensitized inactivation of C. albicans increased with both photosensitizer concentration and irradiation time. After 30 min irradiation, a high photoinactivation (∼5 log) was found for C. albicans treated with 5 μM porphyrin. Also, the photoinactivation of yeast cells was still elevated after two washing steps. However, the photocytotoxicity decreases with an increase in the cell density from 10(6) to 10(8) cells/mL. The high photodynamic activity of these porphyrins was also established by growth delay experiments. This C. albicans strain was susceptible to fluconazole with a MIC of 1.0 μg/mL. The effect of photosensitization and the action of fluconazole were combined to eradicate C. albicans. After a PDI treatment with 1 μM porphyrin and 30 min irradiation, the value of MIC decreased to 0.25 μg/mL. In addition, a complete arrest in cell growth was found by combining both effects. TAPP was similarly effective to photoinactivate C. albicans than TAPP(4+). This porphyrin without intrinsic positive charges contains basic amino groups, which can be protonated at physiological pH. Moreover, an enhancement in the antifungal action was found using both therapies because lower doses of the agents were required to achieve cell death.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antifungal; Candida albicans; Fluconazole; Photoinactivation; Porphyrin

Mesh:

Substances:

Year:  2015        PMID: 26498876     DOI: 10.1016/j.pdpdt.2015.10.005

Source DB:  PubMed          Journal:  Photodiagnosis Photodyn Ther        ISSN: 1572-1000            Impact factor:   3.631


  4 in total

1.  New insights into the antimicrobial blue light inactivation of Candida albicans.

Authors:  Edgardo N Durantini
Journal:  Virulence       Date:  2016-03-07       Impact factor: 5.882

2.  Novel meso-substituted porphyrin derivatives and its potential use in photodynamic therapy of cancer.

Authors:  Pablo Vallecorsa; Gabriela Di Venosa; M Belén Ballatore; Dario Ferreyra; Leandro Mamone; Daniel Sáenz; Gustavo Calvo; Edgardo Durantini; Adriana Casas
Journal:  BMC Cancer       Date:  2021-05-13       Impact factor: 4.430

3.  Photodynamic Inactivation Potentiates the Susceptibility of Antifungal Agents against the Planktonic and Biofilm Cells of Candida albicans.

Authors:  Mu-Ching Huang; Mandy Shen; Yi-Jhen Huang; Hsiao-Chi Lin; Chin-Tin Chen
Journal:  Int J Mol Sci       Date:  2018-02-01       Impact factor: 5.923

Review 4.  Antimicrobial Photodynamic Therapy: Latest Developments with a Focus on Combinatory Strategies.

Authors:  Raphaëlle Youf; Max Müller; Ali Balasini; Franck Thétiot; Mareike Müller; Alizé Hascoët; Ulrich Jonas; Holger Schönherr; Gilles Lemercier; Tristan Montier; Tony Le Gall
Journal:  Pharmaceutics       Date:  2021-11-24       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.